Amygdala scores $2m NIAAA grant to develop alcohol use disorder therapy
The grant will support the early development of Amygdala’s ALDH2 Inhibitor currently in pre-clinical development.
The grant will support the early development of Amygdala’s ALDH2 Inhibitor currently in pre-clinical development.
What's Your Reaction?
